-
Mashup Score: 1Join me! | Key Findings and Expert Recommendations in Gynecologic Malignancies: Independent 2023 Conference/Congress Coverage - 48714 - 2 year(s) ago
Expert slides, podcasts, commentaries, and more on emerging data in gynecologic cancers from key 2023 conferences, from Clinical Care Options (CCO)
Source: clinicaloptions.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
By The ASCO Post Staff Posted: 3/30/2023 10:54:00 AM Last Updated: 3/30/2023 1:57:12 PM Researchers have found that concurrent treatment with gemcitabine as well as cisplatin and intensity-modulated radiation therapy may effectively increase the pathologic complete response rates in patients with locally…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
More on @NRGonc trial @GOG 279 at #SGOmtg! #Gemcitabine Plus #Cisplatin and #IMRT Produces Complete Responses in #vulvarcancer. From @ASCOPost #gyncsm #NRGatSGO #SGO2023 #clinicaltrial #oncology https://t.co/AIk3evaoQA
-
-
Mashup Score: 0Post | LinkedIn - 2 year(s) ago
Activate to view larger image,
Source: www.linkedin.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Up next at #SGOmtg! #NRGatSGO https://t.co/HX3dx7iktl
-
Expert Insight on New Data From #SGO2023 Informing Treatment for #Endometrialcancer, #CervicalCancer, & #ovariancancer from @CCO_LLC. #gyncsm #NRGatSGO #SGOMtg #clinicaltrial #oncology @NRGonc @GOG @LDuska @KEYTRUDA @jemperli @kisqali_us https://t.co/03HXPTHLyM